DNAket
DNAket is a novel type of ketamine derivative that has been studied for its potential therapeutic applications, particularly in the field of neuroscience and psychiatry. The compound is designed to modulate the activity of the NMDA receptor, a key target in the management of various neurological disorders.
Research on DNAket has focused on its ability to activate the NMDA receptor in a unique way,
In addition to its pharmacological properties, DNAket has been found to have a favorable safety profile, with
Several studies have been conducted to evaluate the efficacy and safety of DNAket in various patient populations.
The development of DNAket is a recent area of research, and its eventual regulatory approval and clinical